FDA docs give Mod­er­na green light, while spot­light­ing dif­fer­ences with Pfiz­er

The US looks set to go from ze­ro to two Covid-19 vac­cines in a week.

On Tues­day, the FDA re­leased its in-house as­sess­ment of Mod­er­na’s mR­NA vac­cine, draw­ing a cau­tious note in one area, but large­ly of­fer­ing a ring­ing en­dorse­ment for a can­di­date that, like Pfiz­er and BioN­Tech’s, has al­ready vast­ly ex­ceed­ed most ex­pert ex­pec­ta­tions. With the New York Times re­port­ing that the FDA plans to au­tho­rize the vac­cine on Fri­day, the US could have two dif­fer­ent vac­cines be­ing trans­port­ed across the coun­try by the start of next week.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER